Coronavirus disease 2019 (COVID-19) pandemics affected many aspects of the socioeconomic structure in Korea, especially in medical practice. As a major route of infection, the respiratory system is a key organ leading to increased risk of mortality an...
Coronavirus disease 2019 (COVID-19) pandemics affected many aspects of the socioeconomic structure in Korea, especially in medical practice. As a major route of infection, the respiratory system is a key organ leading to increased risk of mortality and morbidity. However, it is well known that extra-respiratory involvement of COVID-19 also significantly affects patients’ outcomes. Patients with chronic liver disease are not at increased risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). But, the risk of severe courses of COVID-19 may be different depending on the nature of the chronic liver disease and the presence of advanced fibrosis or cirrhosis. The present topic will summarize current evidences on the risk of infection and severe COVID-19 courses in patients with variable liver diseases.